Drugs News and Research

RSS

Study finds a more effective treatment option for HER2 mutant metastatic breast cancer

Breast cancers with HER2 mutations respond to the drug neratinib, but the responses are variable and often not durable.

23 Jun 2022

New patient safety rules set by TJC are not supported by published evidence, study finds

If health care facilities such as hospitals and nursing homes don't follow patient safety rules set by The Joint Commission (TJC) - the independent organization responsible for accrediting health care facilities - they may lose their accreditation, and consequently, lose patients and millions of dollars every year in funding.

23 Jun 2022

Henry Ford Health participated in a completely virtual heart failure study during the pandemic

Henry Ford Health was part of a multi-institutional heart failure study that was launched and executed completely virtual during the COVID-19 pandemic. The novel study design could serve as a model for future research.

23 Jun 2022

KHN’s ‘What the Health?’: The FDA goes after nicotine

The FDA this week launched a crackdown on smoking and vaping — ordering the vaping device Juul to be taken off the market and announcing its intention to require makers of cigarettes and other tobacco products to reduce the amount of nicotine in them.

23 Jun 2022

Molecular tumor profiling in pediatric cancer patients significantly impacts clinical care

Results of a study of molecular tumor profiling in young patients revealed a high rate of genetic alterations with potential for impacting clinical care, including clarifying diagnoses and treatment with matched, precision cancer drugs.

23 Jun 2022

Researchers discover two important novel aspects of APOE4 gene in Alzheimer's patients

Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia, affecting more than 5.8 million individuals in the U.S.

23 Jun 2022

Researchers model a complex childhood disease on-a-chip

Millions of children in low- and middle-income nations suffer from environmental enteric dysfunction (EED), a chronic inflammatory disease of the intestine that is the second leading cause of death in children under five years old.

23 Jun 2022

New funding to help advance scientific understanding of skin disorders in children and young people

For children and young people, skin disorders can have a devastating impact on physical and mental wellbeing, yet effective treatments are few and far between.

23 Jun 2022

Kratom: A dangerous or beneficial plant?

A new study summarizes the traditional and modern uses of kratom, as well as its pharmacology, benefits, and adverse health impacts.

23 Jun 2022

Midgestation increase in leptin puts child and mother at risk of cardiovascular disease

Before a baby is ever born, critical supply chain problems with nutrition and oxygen can result in premature birth or even death and increase the child and mother's lifelong risk of cardiovascular disease.

23 Jun 2022

Study shows industry sponsorship bias in cost effectiveness analysis for setting new drug prices

Medical industry sponsorship of economic evaluations on new treatments are more likely to be found 'cost-effective' than independent research across a range of diseases.

22 Jun 2022

Study provides better understanding of the brain pathways that control nausea

Nausea is a bit of a catchall sensation for the human body: the unpleasant sick feeling can hit us as a result of everything from pregnancy or a migraine to eating spoiled food or undergoing chemotherapy.

22 Jun 2022

Researchers identify biomarkers that could be targets for novel drugs to treat glioblastoma

Biomarkers that could be targets for novel drugs to treat glioblastoma brain tumors have been identified by investigators at Georgetown Lombardi Comprehensive Cancer Center, providing hope for a cancer that is highly lethal.

22 Jun 2022

Simple blood test can predict liver cancer risk in NAFLD patients

An estimated one-quarter of adults in the U.S. have nonalcoholic fatty liver disease (NAFLD), an excess of fat in liver cells that can cause chronic inflammation and liver damage, increasing the risk of liver cancer.

22 Jun 2022

Lung cancer patients treated with immune checkpoint inhibitors can be safely vaccinated against COVID-19, study says

Cancer patients have received priority status to receive COVID-19 vaccinations but there is limited data regarding the safety and efficacy of the vaccines for patients treated for lung cancer with immune checkpoint inhibitors.

22 Jun 2022

Wearable activity trackers combined with AI may aid in early identification of COVID-19

Wearable activity trackers that monitor changes in skin temperature and heart and breathing rates, combined with artificial intelligence (AI), might be used to pick up COVID-19 infection days before symptoms start, suggests preliminary research published in the open access journal BMJ Open.

22 Jun 2022

Scientists evaluate JNK inhibitors in treating moderate to severe COVID-19 patients

Scientists have described the clinical outcomes in hospitalized COVID-19 patients who have been treated with JNK inhibitors together with standard of care.

22 Jun 2022

New weight loss treatment is marked by heavy marketing and modest results

First came the "edible billboard," which appeared last year during the holidays in New York's East Village loaded with cake treats. Then, in late January, came the national marketing campaign, with TV and digital media promoting the idea that trying to lose weight doesn't mean a person can't enjoy eating.

22 Jun 2022

New technology can revitalize the bactericidal effects of conventional antibiotics in MDR E.coli infections

A research team led by Professor Kelvin Yeung Wai-kwok from the Department of Orthopaedics and Traumatology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong (HKUMed) has designed a non-invasive technology to revitalize the bactericidal effects of conventional antibiotics in multidrug-resistant (MDR)Escherichia coli (E. coli)-associated deep tissue infections, such as urinary tract and peritoneal infections.

22 Jun 2022

Potential SARS-CoV-2 antivirals based on host miRNAs

A recent research paper posted to the bioRxiv* preprint server demonstrated micro ribonucleic acids (miRNAs) as potential antiviral options against various coronaviruses (CoVs), including severe acute respiratory syndrome CoV 2 (SARS-CoV-2).

21 Jun 2022

Drugs News and Research

Study finds a more effective treatment option for HER2 mutant metastatic breast cancer

New patient safety rules set by TJC are not supported by published evidence, study finds

Henry Ford Health participated in a completely virtual heart failure study during the pandemic

KHN’s ‘What the Health?’: The FDA goes after nicotine

Molecular tumor profiling in pediatric cancer patients significantly impacts clinical care

Researchers discover two important novel aspects of APOE4 gene in Alzheimer's patients

Researchers model a complex childhood disease on-a-chip

New funding to help advance scientific understanding of skin disorders in children and young people

Kratom: A dangerous or beneficial plant?

Midgestation increase in leptin puts child and mother at risk of cardiovascular disease

Study shows industry sponsorship bias in cost effectiveness analysis for setting new drug prices

Study provides better understanding of the brain pathways that control nausea

Researchers identify biomarkers that could be targets for novel drugs to treat glioblastoma

Simple blood test can predict liver cancer risk in NAFLD patients

Lung cancer patients treated with immune checkpoint inhibitors can be safely vaccinated against COVID-19, study says

Wearable activity trackers combined with AI may aid in early identification of COVID-19

Scientists evaluate JNK inhibitors in treating moderate to severe COVID-19 patients

New weight loss treatment is marked by heavy marketing and modest results

New technology can revitalize the bactericidal effects of conventional antibiotics in MDR E.coli infections

Potential SARS-CoV-2 antivirals based on host miRNAs

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News